tiprankstipranks
Entrada Therapeutics Inc (TRDA)
NASDAQ:TRDA
US Market
TRDA
Entrada Therapeutics Inc
RESEARCH TOOLSreports
Want to see TRDA full AI Analyst Report?

Entrada Therapeutics Inc (TRDA) Income Statement

149 Followers

Entrada Therapeutics Inc Income Statement

Last quarter (Q4 2025), Entrada Therapeutics Inc's total revenue was $1.30M, a decrease of -96.53% from the same quarter last year. In Q4, Entrada Therapeutics Inc's net income was $-39.16M. See Entrada Therapeutics Inc’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 25.42M$ 210.78M$ 129.01M$ 0.00$ 0.00
Gross Profit
$ 21.32M$ 210.78M$ 129.01M$ 0.00$ 0.00
Operating Expenses
$ 177.32M$ 163.77M$ 132.18M$ 97.25M$ 51.13M
Depreciation and Amortization
$ 425.00K$ 3.77M$ 2.84M$ 1.90M$ 1.12M
EBITDA
$ -142.40M$ 47.01M$ -321.00K$ -95.35M$ -50.01M
Operating Income
$ -156.00M$ 47.01M$ -3.16M$ -97.25M$ -51.13M
Other Income/Expenses
$ 13.17M$ 19.47M$ 15.22M$ 2.63M$ -31.00K
Pretax Income
$ -142.83M$ 66.48M$ 12.06M$ -94.62M$ -51.16M
Net Income
$ -143.75M$ 65.63M$ -6.68M$ -94.62M$ -51.16M
Per Share Metrics
Basic EPS
$ -3.47$ 1.76$ -0.20$ -2.79$ -1.60
Diluted EPS
$ -3.47$ 1.68$ -0.20$ -2.79$ -1.60
Weighted Average Shares Outstanding
 41.37M 37.31M 33.05M 31.29M 31.22M
Weighted Average Shares Outstanding (Diluted)
 41.37M 39.00M 33.05M 31.29M 31.22M
Currency in USD

Entrada Therapeutics Inc Earnings and Revenue History